Free Trial

Scienture (SCNX) Competitors

Scienture logo
$1.21 -1.01 (-45.50%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$1.19 -0.02 (-1.65%)
As of 08/14/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SCNX vs. MMLP, UFG, DLXY, WGRX, NHTC, GDC, RAVE, LTCH, COSM, and CGTL

Should you be buying Scienture stock or one of its competitors? The main competitors of Scienture include Martin Midstream Partners (MMLP), Uni-Fuels (UFG), Delixy (DLXY), Wellgistics Health (WGRX), Natural Health Trends (NHTC), GD Culture Group (GDC), Rave Restaurant Group (RAVE), Latch (LTCH), Cosmos Health (COSM), and Creative Global Technology (CGTL). These companies are all part of the "wholesale" industry.

Scienture vs. Its Competitors

Martin Midstream Partners (NASDAQ:MMLP) and Scienture (NASDAQ:SCNX) are both small-cap wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, Scienture had 12 more articles in the media than Martin Midstream Partners. MarketBeat recorded 13 mentions for Scienture and 1 mentions for Martin Midstream Partners. Martin Midstream Partners' average media sentiment score of 1.88 beat Scienture's score of 0.37 indicating that Martin Midstream Partners is being referred to more favorably in the media.

Company Overall Sentiment
Martin Midstream Partners Very Positive
Scienture Neutral

Scienture has lower revenue, but higher earnings than Martin Midstream Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Martin Midstream Partners$707.62M0.19-$5.21M-$0.39-8.92
Scienture$140K139.41$9.07MN/AN/A

34.9% of Martin Midstream Partners shares are owned by institutional investors. Comparatively, 5.7% of Scienture shares are owned by institutional investors. 17.0% of Martin Midstream Partners shares are owned by insiders. Comparatively, 49.7% of Scienture shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Martin Midstream Partners has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500. Comparatively, Scienture has a beta of 2.94, indicating that its stock price is 194% more volatile than the S&P 500.

Martin Midstream Partners has a net margin of -2.19% compared to Scienture's net margin of -10,364.22%. Martin Midstream Partners' return on equity of 0.00% beat Scienture's return on equity.

Company Net Margins Return on Equity Return on Assets
Martin Midstream Partners-2.19% N/A -2.76%
Scienture -10,364.22%-24.47%-19.30%

Summary

Martin Midstream Partners beats Scienture on 6 of the 11 factors compared between the two stocks.

Get Scienture News Delivered to You Automatically

Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SCNX vs. The Competition

MetricScientureMED IndustryMedical SectorNASDAQ Exchange
Market Cap$35.81M$2.48B$5.61B$9.84B
Dividend YieldN/A1.76%4.61%4.07%
P/E RatioN/A22.0530.2925.74
Price / Sales139.41742.42463.41115.83
Price / CashN/A184.4138.2159.48
Price / Book0.254.838.826.15
Net Income$9.07M$31.61M$3.25B$265.06M
7 Day Performance-42.38%4.55%3.70%2.60%
1 Month Performance-29.24%5.69%5.84%2.83%
1 Year PerformanceN/A12.71%29.92%25.58%

Scienture Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SCNX
Scienture
N/A$1.21
-45.5%
N/AN/A$35.81M$140K0.00N/ATrending News
Earnings Report
Gap Down
High Trading Volume
MMLP
Martin Midstream Partners
1.4532 of 5 stars
$3.07
+2.3%
N/A-6.7%$117.17M$707.62M-7.871,679Positive News
UFG
Uni-Fuels
N/A$2.94
+5.0%
N/AN/A$84M$155.19M0.0017Positive News
Gap Down
DLXY
Delixy
N/A$4.70
-4.9%
N/AN/A$80.77MN/A0.00N/AQuiet Period Expiration
Gap Down
WGRX
Wellgistics Health
N/A$0.81
-1.3%
N/AN/A$62.21M$18.13M0.0031News Coverage
Lockup Expiration
Gap Down
NHTC
Natural Health Trends
1.9306 of 5 stars
$4.98
+4.0%
N/A-35.3%$55.15M$42.96M166.06140Positive News
Ex-Dividend
High Trading Volume
GDC
GD Culture Group
0.9729 of 5 stars
$3.21
-0.9%
N/A+65.7%$54.42MN/A-3.1260News Coverage
Earnings Report
Short Interest ↓
Gap Down
RAVE
Rave Restaurant Group
1.3472 of 5 stars
$2.81
-1.7%
N/A+58.0%$40.65M$12.15M14.7920Short Interest ↑
LTCH
Latch
N/A$0.16
+33.3%
N/A-69.8%$26.37M$48.39M0.00420News Coverage
Gap Up
COSM
Cosmos Health
1.6617 of 5 stars
$0.88
-2.5%
N/A-18.8%$25.88M$54.43M-0.81100Upcoming Earnings
Short Interest ↑
CGTL
Creative Global Technology
N/A$0.97
-3.0%
N/AN/A$21.44M$35.61M0.00N/AGap Down

Related Companies and Tools


This page (NASDAQ:SCNX) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners